MUSCARINIC M1I RECEPTOR AGONISTS FOR PAIN MANAGEMENT
Application 2138/KOLNP/2005 published 2007-07-27, filed 2005-10-27
Disclosed herein are compounds and methods for treating chronic neuropathic pain. It has been discovered that compounds that selectively interact with a muscarinic receptor subtype are effective in treating neuropathic pain. Specifically, compounds that selectively interact with the M1 muscarinic receptor subtype may be used.
Applicant
1)ACADIA PHARMA CEUTICALS INC
:3911 SORENTO VALLEY BLVD, SAN DIEGO, CA 92121-1402, U.S.A.
Inventor
1)DAVIS, ROBERT, R 2)VANOVER, KIMBERLY 3)RODRIGUEZ, MARIO
International Info
Classification: A61K 31/454, 31/538
Publication Number: WO 2004/087158
Application Date: 2004-03-26
Priority Information
60/459 U.S.A. 2003-03-28